Detalles de la búsqueda
1.
Prognostic significance of circulating tumor cells and tumor related transcripts in small cell lung cancer: A step further to clinical implementation.
Int J Cancer;
154(12): 2189-2199, 2024 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38353516
2.
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
Br J Cancer;
2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750115
3.
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.
Int J Mol Sci;
25(7)2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612799
4.
Effect of short-term storage of blood samples on gene expression in lung cancer patients.
Clin Chem Lab Med;
61(2): 294-301, 2023 01 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36395488
5.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Lancet Oncol;
22(1): 51-65, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33285097
6.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med;
379(23): 2220-2229, 2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280641
7.
Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.
N Engl J Med;
379(21): 2027-2039, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30280657
8.
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer.
N Engl J Med;
378(22): 2078-2092, 2018 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29658856
9.
Pre-radiosurgery leucocyte ratios and modified glasgow prognostic score predict survival in non-small cell lung cancer brain metastases patients.
J Neurooncol;
151(2): 257-265, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33179214
10.
Plain language summary of the final results from the GioTag study.
Future Oncol;
17(25): 3285-3290, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34107727
11.
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Lancet Oncol;
21(3): 387-397, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035514
12.
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Lancet;
394(10212): 1929-1939, 2019 11 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31590988
13.
Real-world treatment duration in ALK-positive non-small-cell lung cancer patients receiving brigatinib through the early access program.
Future Oncol;
16(15): 1031-1041, 2020 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-32338548
14.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: final analysis of the GioTag study.
Future Oncol;
16(34): 2799-2808, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32854536
15.
Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: updated analysis of the observational GioTag study.
Future Oncol;
15(25): 2905-2914, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31370698
16.
Sequential treatment with afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: an observational study.
Future Oncol;
14(27): 2861-2874, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30336693
17.
Complete remission of intrathecal metastases with lorlatinib therapy in a heavily pretreated ALK-positive lung cancer patient.
Anticancer Drugs;
28(8): 928-930, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28628492
18.
How can better identification of T790M help to inform treatment sequencing decisions in EGFR mutation-positive non-small-cell lung cancer?
Future Oncol;
15(25): 2895-2898, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31030557
19.
Expression of cytokines in pleural effusions and corresponding cell lines of small cell lung cancer.
Transl Lung Cancer Res;
13(1): 5-15, 2024 Jan 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38405004
20.
Unmet needs in EGFR exon 20 insertion mutations in Central and Eastern Europe: reimbursement, diagnostic procedures, and treatment availability.
BMC Proc;
18(Suppl 3): 2, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233854